Cadence Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-33,286
| Closed | -$665K | – | 662 |
|
|
2018
Q2 | $665K | Buy |
33,286
+3,593
| +12% | +$71.8K | 0.04% | 460 |
|
|
2018
Q1 | $520K | Buy |
29,693
+933
| +3% | +$16.3K | 0.03% | 498 |
|
|
2017
Q4 | $709K | Buy |
28,760
+2,072
| +8% | +$51.1K | 0.05% | 435 |
|
|
2017
Q3 | $689K | Buy |
+26,688
| New | +$689K | 0.04% | 443 |
|
|
2017
Q2 | – | Sell |
-7,910
| Closed | -$236K | – | 658 |
|
|
2017
Q1 | $236K | Buy |
+7,910
| New | +$236K | 0.02% | 631 |
|